Skip to content

13F-HR filed by Redmile Group, LLC

Redmile Group, LLC filed this 13F-HR for the quarter ended 2014-09-30, filed 2014-11-14, with 54 holding rows worth $865,753,000.

Accession
0001321300-14-000007
Filed
2014-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2014

A holdings report, 54 entries on the cover page, a total value of $865,753,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $865,753,000 with VALUE read as thousands by filing date, 13F file number 028-12776. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ISHARES TR464287955PUT450,000$49,208,000thousands by filing dateput
VALEANT PHARMACEUTICALS INTL91911K102COM332,567$43,633,000thousands by filing date
ACTAVIS PLCG0083B108SHS163,898$39,545,000thousands by filing date
CLOVIS ONCOLOGY INC189464100COM784,459$35,583,000thousands by filing date
CELGENE CORP151020104COM369,400$35,012,000thousands by filing date
AMICUS THERAPEUTICS INC03152W109COM5,706,906$33,956,000thousands by filing date
MCKESSON CORP COM58155Q103Stock161,765$31,491,000thousands by filing date
CHIMERIX INC COM16934W106Stock1,121,032$30,963,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock8,342,045$29,781,000thousands by filing date
RECEPTOS, INC.756207106COMMON STOCK439,878$27,321,000thousands by filing date
TRIVASCULAR TECHNOLOGIES INC89685A102COM1,751,518$25,534,000thousands by filing date
RITEAID CORP767754104COM5,260,710$25,462,000thousands by filing date
HCA Healthcare Inc40412C101COM328,292$23,151,000thousands by filing date
CASTLIGHT HEALTH INC CL B14862Q100Stock1,683,817$21,789,000thousands by filing date
AVALANCHE BIOT05337G107Common Stock699,460$21,531,000thousands by filing date
Mallinckrodt PlcG5785G107SHS231,389$20,860,000thousands by filing date
GLOBUS MED INC CL A379577208Stock966,300$19,007,000thousands by filing date
CUBIST PHARMACEUTICALS INC229678107COM283,756$18,824,000thousands by filing date
ZS PHARMA INC98979G105Common Stock474,132$18,600,000thousands by filing date
NUVASIVE INC670704105COM498,441$17,381,000thousands by filing date
HEALTHWAYS INC422245100COM1,026,503$16,445,000thousands by filing date
OXFORD IMMUNOTEC GLOBAL PLCG6855A103ORD SHS1,066,415$16,284,000thousands by filing date
NANOSTRING TECHNOLOGIES INC63009R109COM1,453,655$15,903,000thousands by filing date
Lowes Companies Inc42222G108LOW334,935$15,444,000thousands by filing date
MODEL N INC607525102COM1,457,278$14,369,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock1,090,624$14,233,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK1,003,496$13,758,000thousands by filing date
STANDARD BIOTOOLS INC34385P108COM559,622$13,711,000thousands by filing date
WELLCARE HEALTH PLANS INC94946T106COM225,033$13,578,000thousands by filing date
UNIVERSAL HLTH SVCS INC CL B913903100Stock123,792$12,936,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM177,079$12,778,000thousands by filing date
PUMA BIOTECHNOLOGY INC74587V107COMMON STOCK51,025$12,173,000thousands by filing date
PROQR THERAPEUTICS NVN71542109SHS EURO765,232$12,067,000thousands by filing date
ACCURAY INC DEL004397105COM1,653,128$12,002,000thousands by filing date
CIVITAS SOLUTIONS INC17887R102COM619,236$9,672,000thousands by filing date
KYTHERA BIOPHARMACEUTICALS I501570105COM281,479$9,221,000thousands by filing date
ALIGN TECHNOLOGY INC COM016255101Stock172,772$8,929,000thousands by filing date
CYBERONICS23251P102COMMON STOCK172,900$8,846,000thousands by filing date
CARDIOVASCULAR SYSTEMS INC141619106COMMON STOCK370,208$8,748,000thousands by filing date
FLEXION THERAPEUTICS INC33938J106COM465,933$8,508,000thousands by filing date
LOXO ONCOLOGY INC548862101COM540,300$7,094,000thousands by filing date
ACHAOGEN INC004449104COM770,422$6,903,000thousands by filing date
TOKAI PHARMACEUTICALS INC COM88907J107Stock414,330$6,273,000thousands by filing date
HMS HLDGS CORP40425J101COM303,571$5,722,000thousands by filing date
SEATTLE GENETICS INC812578102COM128,230$4,768,000thousands by filing date
CLOVIS ONCOLOGY INC189464900CALL100,000$4,536,000thousands by filing datecall
EHEALTH INC28238P109COM177,788$4,290,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM49,200$3,018,000thousands by filing date
PROTHENA CORP PLC SHSG72800108Stock125,973$2,792,000thousands by filing date
INTERCEPT PHARMACEUTICALS IN45845P108COM2,212$524,000thousands by filing date
ISHARES TR464287556ISHARES BIOTECH1,652$452,000thousands by filing date
OTONOMY INC68906L105COM18,400$442,000thousands by filing date
MARKET VECTORS PHARM ETF T57060U217ETF6,500$413,000thousands by filing date
ISHARES TR464288828US HLTHCR PR ETF2,700$289,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001321300-14-000007this filing2014-11-14acceptance time not in the bulk data set